Who Wegovy is made by — and why it matters

The common misconception: that Wegovy and Ozempic are the same product

A question our prescribers hear most weeks is whether Wegovy and Ozempic are interchangeable. Both are made by Novo Nordisk and both contain semaglutide, but they are not the same product, and the distinction is not a technicality. Ozempic is licensed in the UK for type 2 diabetes. Wegovy is licensed for weight management, at a higher maintenance dose (2.4 mg weekly, with the MHRA having approved a 7.2 mg option in 2026) and in a differently designed pen. Prescribing Ozempic for weight loss is an off-label use that sits outside the licensed indication; it also diverts supply from people with diabetes who depend on it. The comparison between Wegovy and Ozempic is worth reading in full if this has come up for you. Novo Nordisk markets the products under different brand names precisely because the clinical programmes, doses and approved patient populations differ. Knowing who makes Wegovy is less useful than knowing which Novo Nordisk product carries the right UK licence for the purpose you have in mind.

Novo Nordisk's role in the UK supply chain for genuine Wegovy

Novo Nordisk manufactures semaglutide at production facilities in Denmark and distributes it through authorised supply chains into each market. In the UK, that means working with MHRA-licensed wholesalers and GPhC-registered pharmacies. When you obtain Wegovy through a regulated UK pharmacy, the pen you receive has passed through that chain intact, with cold-chain logistics, batch traceability, and packaging that matches the MHRA-approved product. The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media; some seized fakes were found to contain insulin rather than semaglutide, with serious consequences for the people who used them. If you want to understand more about how the medicine is produced and quality-controlled, the manufacturing process behind Wegovy page goes into that detail. For now, the practical point is straightforward: the manufacturer matters because only medicines produced and distributed through the licensed route carry any guarantee of being what they say they are. Verifying a pharmacy on the GPhC register is the fastest way to check you are dealing with a legitimate dispenser.

What Novo Nordisk's semaglutide programme means for UK patients in 2026

Novo Nordisk's investment in semaglutide has resulted in several distinct UK-licensed products. Beyond Wegovy, the company received MHRA approval in June 2026 for Wegovy tablets, the first oral GLP-1 medicine licensed for weight management in the UK, containing semaglutide co-formulated with an absorption enhancer. The 7.2 mg injectable dose, approved by the MHRA on 14 April 2026, extended the ceiling for the injection further still. There is also Rybelsus, Novo Nordisk's oral semaglutide tablet licensed for type 2 diabetes at lower doses, not for weight management. Each product sits in its own licensed lane. You can explore the company context around Wegovy's authorisation or read about who developed semaglutide and the research pathway that led to its approval. The NHS provides patient-level information on semaglutide at nhs.uk/medicines/semaglutide, including what it is used for and what the common side effects look like. Knowing the manufacturer's full portfolio helps you ask sharper questions at a consultation, which medicine, which dose, which licence, and which supply route.

Getting Wegovy through a regulated UK pharmacy

Because Wegovy is a prescription-only medicine, Novo Nordisk's role ends at the point of manufacture and licensed distribution. After that, a prescriber must assess your clinical picture before any supply can happen lawfully. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally on the day it is submitted. Identity and weight are verified, and the prescriber considers your full health history before deciding whether Wegovy is appropriate. If you are already on treatment elsewhere and are considering switching provider, our guide to obtaining Wegovy through a UK pharmacy sets out what to expect. For anyone at the earlier stage of weighing up options, the weight-loss treatment overview covers how Wegovy fits alongside other licensed medicines. The clinical team page introduces the prescribers who carry out those reviews. If you have specific questions before starting, our FAQs cover the most common ones. Treatment is dispatched the same day it is approved, tracked by DPD, and delivered free the next working day in plain, unbranded packaging. To find out whether you are eligible, the first step is a free consultation with no obligation to proceed.

Speak to our prescribers, start your free consultation here.